A1/A2 polymorphism of GpIIIa gene and a risk of aneurysmal subarachnoid haemorrhage

Biochem Biophys Res Commun. 2009 May 29;383(2):228-30. doi: 10.1016/j.bbrc.2009.03.156. Epub 2009 Apr 5.

Abstract

Platelet glycoproteins are involved in pathophysiology of cerebrovascular diseases. The aim of this study was to investigate the association between the GpIIIa gene A1/A2 polymorphism and a risk of aneurysmal subarachnoid haemorrhage (SAH) in a Polish population. In a case-control study we genotyped 288 Caucasian patients with aneurysmal SAH and 457 age-, gender- and race-matched controls. The GpIIIa A1/A2 polymorphism was genotyped with RFLP technique. No difference was found in the distribution of the polymorphism between the cases and controls (cases: A1A1-201 (69.8%), A1A2-83 (28.8%) and A2A2-4 (1.4%) vs. controls: A1A1-323 (70.7%); A1A2-128 (28.0%); A2A2-6 (1.3%), P>0.05. In a multivariate analysis female gender (OR=1.950; 95%CI: 1.308-2.907), hypertension (OR=4.774; 95%CI: 3.048-7.478) and smoking (OR=2.034; 95%CI: 1.366-3.030), but not GpIIIa A1/A2 polymorphism, were independent risk factors for aneurysmal SAH. The GpIIIa A1/A2 polymorphism is not a risk factor of aneurysmal SAH in a Polish population.

MeSH terms

  • Female
  • Humans
  • Integrin beta3 / genetics*
  • Male
  • Middle Aged
  • Poland / epidemiology
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Risk
  • Subarachnoid Hemorrhage / epidemiology*
  • Subarachnoid Hemorrhage / genetics*

Substances

  • Integrin beta3